Impact of ovarian stimulation on corpus luteum function and embryonic implantation

被引:92
作者
Tavaniotou, A [1 ]
Albano, C [1 ]
Smitz, J [1 ]
Devroey, P [1 ]
机构
[1] Free Univ Brussels, Ctr Reprod Med, B-1090 Brussels, Belgium
关键词
corpus luteum; endometrial biopsy; ovarian stimulation; luteinizing hormone; luteal phase; in-vitro fertilization; gonadotrophin-releasing hormone;
D O I
10.1016/S0165-0378(01)00134-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The luteal phase has been found to be defective in virtually all the stimulation protocols used in in-vitro fertilization (IVF), indicating that common mechanisms might be involved despite the use of different drugs. A normal luteal phase is characterised by a normal hormonal environment, normal progesterone secretion by the corpus luteum and adequate endometrial secretory transformation. Luteinizing hormone supports the corpus luteum and luteal luteinizing hormone (LH) levels have been found to be reduced in human menopausal gonadotrophin (HMG), gonadotrophin-releasing hormone (GnRH)-agonist/HMG and GnRH-antagonist/HMG protocols, probably leading to an insufficient corpus luteum function. Supraphysiological steroid serum concentrations routinely observed in stimulated cycles may adversely affect LH secretion and induce a luteal-phase defect. In turn, these high steroid serum concentrations may advance early luteal-phase endometrial development leading to embryo-endometrial asynchrony and decreased pregnancy rates in IVF cycles. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 28 条
  • [1] The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetvorelix
    Albano, C
    Grimbizis, G
    Smitz, J
    Riethmüller-Winzen, H
    Reissmann, T
    Van Steirteghem, A
    Devroey, P
    [J]. FERTILITY AND STERILITY, 1998, 70 (02) : 357 - 359
  • [2] Luteal phase and clinical outcome after human menopausal gonadotrophin gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization intracytoplasmic sperm injection cycles
    Albano, C
    Smitz, J
    Tournaye, H
    Riethmüller-Winzen, H
    Van Steirteghem, A
    Devroey, P
    [J]. HUMAN REPRODUCTION, 1999, 14 (06) : 1426 - 1430
  • [3] Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization
    Beckers, NGM
    Laven, JSE
    Eijkemans, MJC
    Fauser, BCJM
    [J]. HUMAN REPRODUCTION, 2000, 15 (01) : 43 - 49
  • [4] HUMAN ENDOMETRIAL MATURATION IS MARKEDLY IMPROVED AFTER LUTEAL SUPPLEMENTATION OF GONADOTROPIN-RELEASING-HORMONE ANALOG HUMAN MENOPAUSAL GONADOTROPIN-STIMULATED CYCLES
    BOURGAIN, C
    SMITZ, J
    CAMUS, M
    ERARD, P
    DEVROEY, P
    VANSTEIRTEGHEM, AC
    KLOPPEL, G
    [J]. HUMAN REPRODUCTION, 1994, 9 (01) : 32 - 40
  • [5] A pilot study involving minimal ovarian stimulation for in vitro fertilization: extending the "follicle-stimulating hormone window" combined with the gonadotropin-releasing hormone antagonist cetrorelix
    de Jong, D
    Macklon, NS
    Fauser, BCJM
    [J]. FERTILITY AND STERILITY, 2000, 73 (05) : 1051 - 1054
  • [6] THE GONADOTROPIN-RELEASING-HORMONE ANTAGONIST (NAL-GLU) ACUTELY BLOCKS THE LUTEINIZING-HORMONE SURGE BUT ALLOWS FOR RESUMPTION OF FOLLICULOGENESIS IN NORMAL WOMEN
    DITKOFF, EC
    CASSIDENTI, DL
    PAULSON, RJ
    SAUER, MV
    PAUL, WL
    RIVIER, J
    YEN, SSC
    LOBO, RA
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (06) : 1811 - 1817
  • [7] Expression of gonadotropin-releasing hormone (GnRH) gene in human uterine endometrial tissue
    Dong, KW
    Marcelin, K
    Hsu, MI
    Chiang, CM
    Hoffman, G
    Roberts, JL
    [J]. MOLECULAR HUMAN REPRODUCTION, 1998, 4 (09) : 893 - 898
  • [8] EDWARDS RG, 1980, BRIT J OBSTET GYNAEC, V87, P737, DOI 10.1111/j.1471-0528.1980.tb04610.x
  • [9] PRESERVED PITUITARY-RESPONSE UNDER OVARIAN STIMULATION WITH HMG AND GNRH ANTAGONISTS (CETRORELIX) IN WOMEN WITH TUBAL INFERTILITY
    FELBERBAUM, RE
    REISSMANN, T
    KUPKER, W
    BAUER, O
    ALHASANI, S
    DIEDRICH, C
    DIEDRICH, K
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1995, 61 (02): : 151 - 155
  • [10] ESTROGEN-INDUCED HUMAN LUTEOLYSIS
    GORE, BZ
    CALDWELL, BV
    SPEROFF, L
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 36 (03) : 615 - 617